Member Info for williamro

Well said.

Won't be long now.....

Many CEOs stay for a shortish time, create havoc, move on before found out and leave the mess for their successors to sort out and repeat the process many times hopping from one company to another. Another feature, sometimes known as the Peter Principle, is that people are promoted to the level at which they are shown to be incompetent but no further.

Selling out to larger companies should be resisted as I see huge growth in AGL income/eventual profits over the next 5/10 years and doubt if growth in profits of a successful take over company would be at the same rate when diluted by other business profits. No doubt those looking for a quick buck would be tempted to sell as we have seen here.

If you want guarantees invest in UK Government bonds or in a Building Society or bank account at miserable rates.

How many he sells will partly depend upon what CGT liability any sale will produce. He may or may not have CGT losses to offset or gains elsewhere to consider.

I believe the price is dropping as income growth will be slow and investors think they can do better elsewhere in the short term. Big good news and FDA approval should strongly reverse this trend. A good buying opportunity.

AGL is more of a one-track pony whereas Biogen is producing many different medications. As such AGL has most of its eggs in one basket which makes it more open to competition to build a similar filter. However, if as seems likely, Parsortex is very successful, it will be the goose that lays the golden egg for both cancer sufferers and investors. Cash receipts to AGL will be years in building up.

I have suspected for some time that there is manipulation of the share price. Today and yesterday, when buys have outpaced sales by 3 to the price goes down. Apart from MMs can anyone suggest who may be behind this apparent departure from normal economic theory? late announcement of trades and after-hours trades do not assist. The total number of shares sold usually exceeds the listed buys and sales sometimes by a large margin so we are not seeing the full story. This is also compounded by the fact that the algorithm often wrongly defines buys and sales.

Presumably, FDA approval will spur on the pharma coys to develop many more treatments for all the different kinds of cancer although some no doubt are already doing this.

Some weeks ago Cambridge University held a webinar on the detection of cancer using liquid biopsies but they did not mention Angle or Parsortix. I asked via the webinar what they thought of Parsortix but got no reply so I emailed them again with the same question but again there was silence. I was not impressed but maybe they did not wish to acknowledge the competition which may be years ahead of them. Perhaps our MD with his Cambridge background could enlighten them.

I am an LTH and had a cancerous prostate removed more than a decade ago and see great promise in Parsortix for all kinds of cancers.

How is it that the holding numbers do not increase by the numbers of trades even going back many weeks?

It seems that when the spread is low, about 1%, the computer cannot differentiate accurately between buys and sells.

Can anyone explain how/why out of hours selling takes place as it can be misleading, possibly unfair and distorts the market? The same could be said about delayed reporting of trades. Here there are also often trades shown in the panel top left (on PCs) which do not appear in the lower right panel where buys and sells are listed and can be added together. To spot trends one often has to rely largely on instinct rather than upon what is shown here

If you sell and then buy a particular share in the same tax year within 30 days then HMRC ignore these deals for CGT purposes and you will be taxed as if they sell and buy never took place

Assuming you have not used up your annual CGT allowance of £20,000 you can do a Bed and ISA to save future CGT within the ISA. Most platforms offer this facility at a specially reduced rate. You sell your shares and pay any CGT due but on repurchase inside the ISA there is never any CGT due as ISAs are outside all CGT rules.

The MMs will be loving this. The higher the churn the more they make.

Do not be misled - my buy at 0910.22 today is recorded here as a sell.

You were lying when you dreamt this.

Yesterday's error corrected.

Steady the Buffs. Google it if needed

Surely AGL are looking at a world market not just USA. Many countries will wish to make their own assessments but some will piggyback on the FDA's decision.

If you look in th box headed Angle Share Price it shows Volume. Look in the box headed Trades and add together the number of buys and sells you will often find they are much less than in the first box. There are also many deals shown in the first box which are often not included in the list of detailed trades. So we are not seeing the full picture.

If you click repeatedly on the Angle Share Price icon at the very top left of the page you will find that the times and details of the latest trades listed vary.

Br3xiUK

Looks like your headline will be your tagline.

Learn about investing before committing more hard-earned cash.